Savosolar Oyj: Subscription period for shares based on Savosolar Plc’s Warrant Plan 3-2021 starts on 20 March 2023
Company Announcement 17 March 2023 at 1.30 p.m. (CET)
Subscription period for shares based on Savosolar Plc’s Warrant Plan 3-2021 starts on 20March2023
Savosolar Plc (“Savosolar” or the “Company”) carried out a rights issue during the period between 11October 2021 and 27 October 2021, where warrants were issued to the subscribers free of charge (the “Warrant Plan 3-2021”). The share subscription price based on the warrants of series TO10 (the “Warrants”) has been set to EUR 0.054or SEK 0.60per share.
The subscription price per share for the Warrant Plan 3-2021 is EUR 0.054 or SEK 0.60.
The subscription period for shares that can be subscribed for based on the Warrants is 20 March 2023 – 31 March 2023.
The terms and conditions of the Warrants can be found at https://savosolar.com/investors/share/stock-options-programmes/.
For more information:
CEO Jari Varjotie
Phone: +358 400 419 734
Savosolar in brief
Savosolar has two business areas: Marine Logistics and Renewable Energy.
Marine Logistics (Meriaura Oy) is a major provider of transport for bulk cargo and demanding project deliveries in Northern Europe, especially in the Baltic Sea and North Sea regions. The company provides its customers with competitive and environmentally sustainable marine transport services, which also reduce carbon emissions from marine transport. Its long-term affreightment agreements, modern fleet and strong market position in renewable energy construction projects enable freight that supports environmentally friendly solutions. As part of Marine Logistics, VG-EcoFuel Oy produces recycled biofuels from bio-oils and recycled oils generated as industrial by-products.
The Renewable Energy (Savosolar Oyj) designs and delivers clean energy production systems as comprehensive deliveries. The systems are built around large-scale solar thermal systems implemented using high-performance solar heat collectors manufactured by the company. Other energy production and storage technologies can also be combined with the systems. The company has taken solar thermal technology to a new level, and its collectors have patented nano-coated direct flow absorbers. With this leading technology, Savosolar enables its customers to produce clean and competitive energy.
Savosolar’s shares are listed on Nasdaq First North Growth Market Sweden under the ticker symbol SAVOS and on Nasdaq First North Growth Market Finland under the ticker symbol SAVOH. www.savosolar.com.
The company’s Certified Adviser is Augment Partners AB, email@example.com, tel. +46 8-604 22 55.To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
ObsEva Files Year End 2022 Financial Statements31.3.2023 22:01:00 CEST | Press release
ObsEva FilesYear End 2022 Financial Statements Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 31, 2023 – ObsEva SA (SIX: OBSN / OTC Pink Market: OBSVF), a biopharmaceutical company developing and commercializing novel therapies to improve women’s health, today published its U.S. Annual Report on Form 10-K for Fiscal Year 2022, including the U.S. GAAP financial results for year-end 2022. The U.S. Annual Report on Form 10-K can be accessed in the financial section of the Company’s website, here or directly via the link here. ObsEva expects to publish its Swiss Annual Report to Shareholders, including the financial results for year end 2022 in IFRS, in the week commencing April 24, 2023. About ObsEva ObsEva is a biopharmaceutical company developing novel therapies to improve women’s reproductive health and pregnancy. ObsEva has established a development program focused on improving in vitro fertilization success rates. ObsEva is listed on
Oxurion Publishes 2022 Annual Report31.3.2023 20:42:16 CEST | Press release
Regulated Information Leuven, BELGIUM,Boston, MA, US–March 31, 2023– 07.00 PM CET – Oxurion NV (Euronext Brussels: OXUR) a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, published its annual report for the financial year 2022. The annual report for the year ending December 31, 2022 is available in the “Investors” section of the Company’s website, and can also be downloaded as a PDF. About Oxurion Oxurion (Euronext Brussels: OXUR) is a biopharmaceutical company developing next generation standard of care ophthalmic therapies, which are designed to improve and better preserve vision in patients with retinal disorders including diabetic macular edema (DME), the leading cause of vision loss in working-age people, as well as other conditions. Oxurion intends to play an important role in the treatment of retinal disorders, including the successful development of THR-149, its novel therapeut
Iceland Seafood International hf completes auction of bills31.3.2023 20:33:29 CEST | Press release
Iceland Seafood International hf. has concluded an offering of 3-month bills in the new series ICESEA 23 0705. Total offers for bills in the auction amounted to ISK 1.500 million which were all accepted, at a simple rate of 11.00%. The bills are scheduled to be admitted to trading on Nasdaq Iceland in the coming weeks.
Nokia Corporation: Repurchase of own shares on 31.03.202331.3.2023 20:00:00 CEST | Press release
Nokia Corporation Stock Exchange Release 31 March 2023 at 21:00 EEST Nokia Corporation: Repurchase of own shares on 31.03.2023 Espoo, Finland – On 31 March 2023 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code)Number of sharesWeighted average price / share, EUR*XHEL221,1864.49CEUX21,0654.50AQEU12,3894.49TQEX7,3604.50Total262,0004.49 * Rounded to two decimals On 3 February 2022, Nokia announced that its Board of Directors is initiating a share buyback program under the authorization granted by Nokia’s Annual General Meeting on 8 April 2021 to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The second phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation (EU) 2016/1052 and under the authorization granted by Nokia’s Annual General Meeting on 5 April 2022 started on 2 January 2023 a
Fly Play hf.: Amendments to share option plan31.3.2023 20:00:00 CEST | Press release
Amendments to share option plan As detailed in the Company Description in relation to the listing of shares in Fly Play hf. on Nasdaq First North Iceland, dated June 2021, the Company had, in accordance with the remuneration then in force, implemented a share-based incentive program in the form of option rights whereby the Company granted several members of the management team and other key employees options to purchase shares in the Company as part of their remuneration. Having regard for the purposes of the share-based incentive program referred to above, the Board of Directors has decided to extend the exercise period in relation to share options to purchase a total of 16.666.669 shares in the Company, at a purchase price of ISK 8 per share. For a period of 12 months, these options are therefore exercisable until April 2024, at which point the options expire. The options may be exercised at any time during the exercise period.